<p>Anti-Thymocyte Globulin should only be used by physicians experienced in immunosuppressant therapy in transplantation.<br />
<br />
<strong>Immune-mediated reactions</strong>: Anti-Thymocyte Globulin infusion could result in an anaphylactic reaction.<br />
<br />
<strong>Infusion-associated reactions</strong>: Close compliance with the recommended infusion time may reduce the incidence and severity of infusion-associated reactions.<br />
<br />
<strong>Hematologic effects</strong>: low counts of platelets and white blood cells have been identified and are reversible following dose adjustments. Monitor total white blood cell and platelet counts.<br />
<br />
<strong>Infection</strong>: Infections and reactivation of infections have been reported. Monitor patients and administer anti-infective prophylaxis.<br />
<br />
<strong>Malignancy</strong>: Incidence of malignancies may increase.<br />
<br />
Immunization with attenuated live vaccines is not recommended for patients who have recently received THYMOGLOBULIN. THYMOGLOBULIN may interfere with rabbit antibody&ndash;based immunoassays and with cross-match or panel-reactive antibody cytotoxicity assays.</p>